Sinskey Anthony J's Form 4 filing
YIELD10 Bioscience, Inc. (YTEN) · filed Dec 6, 2021
- Accession no.
- 0001179110-21-010632
- Filed
- Dec 6, 2021
- Trade date
- Dec 2-3, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $17.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinskey Anthony JCIK 0001368753 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Common Stock | PPurchaseAcquired | +2,000 | $4.63 | +$9,260 | 2,309 | Direct | |
| Dec 3, 2021 | Common Stock | PPurchaseAcquired | +2,000 | $4.33F1 | +$8,660 | 4,309 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reflects the average price per share of the common stock purchased. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.3588 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.
Referenced by the price of 1 transaction in Table I.